By Arnaud Gasnier and Anton Svensson A traditional construction and renovation contractor, the Finnish company Picote discovered and filled a niche when it developed a proprietary method of repairing smaller interior pipes without drilling or digging. With 15 years of business expertise, it designed and developed materials, tools and methods
By Alexander Wurzer, Theo Grünewald, Wolfgang Fischer and Axel Karl The phenomena subsumed under the keywords of “fourth industrial revolution” and “Internet of Things” (IoT) is transforming the industrial landscape. With business models in the B2C and B2B segments adapting to these developments, the role of IP—and in particular that
By Klaus Haft Today, patents in Europe provide for national protection on a country-by-country basis. For the future, a Unitary Patent with unitary effect throughout the territory of the participating Member States is under preparation, which will co-exist with today’s system. To enter into force, among others the Agreement on
By John McManus “Aerogen is the first company in the world to develop technologies for high-performance aerosol drug delivery in acute care,” says founder and CEO John Power. The company has established itself as the global market leader in acute care drug delivery for ventilated patients. Strategic partnerships with leading
By Christian Hackl As established players in the industry did not take the start-up Orcan and its new technology seriously, Orcan had to pivot its business model and go the arduous path to develop and install stand-alone products by themselves. Nevertheless, they still had to convince established players to become
By Karin Hofmann Micrel Medical Devices is a family-owned company founded in Greece in 1980. Its first product, an ambulatory syringe pump, allowed patients suffering from thalassaemia, a rare blood disease that is prevalent among people of Mediterranean descent, to be treated at home instead of in hospital. Following that
By Christian Hackl Marinomed was founded in 2006 by four scientists, three of whom still work for the company. It was spun off from the Veterinary University of Vienna, where it is located to this day. With a staff of 25, the company develops biopharmaceutical products based on natural marine
By Thomas Bereuter, Yann Ménière and Ilja Rudyk This article introduces the SME case studies which are the focus of this special issue. It provides an overview of the companies involved, and looks at the main conclusions drawn by the studies on how to address the common challenges of IP
By John Paul and D. Brian Kacedon 1. Taxation of Patent Transfer Obtaining favorable capital gains taxation treatment on payments for transferring patent rights. 2. Reasonable Royalty Using patent litigation settlement agreements to support reasonable royalty damages in later litigation. 3. Infringement by Offers for Sale Avoiding liability for patent
By Dr. Santosh Mohanty and Kaushik Gala The hyper-connected world we live in is fundamentally altering our lives. Digital technologies are challenging long-held norms. Inventions and their related intellectual property rights (IPR) are crucial for enterprises to differentiate themselves in a highly competitive global market. Software enterprises, in particular, are
